Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Sales (2016 - 2025)

Haemonetics has reported Return on Sales over the past 17 years, most recently at 0.13% for Q4 2025.

  • Quarterly results put Return on Sales at 0.13% for Q4 2025, up 2.0% from a year ago — trailing twelve months through Dec 2025 was 0.13% (up 4.0% YoY), and the annual figure for FY2025 was 0.12%, up 3.0%.
  • Return on Sales for Q4 2025 was 0.13% at Haemonetics, up from 0.12% in the prior quarter.
  • Over the last five years, Return on Sales for HAE hit a ceiling of 0.18% in Q1 2025 and a floor of 0.05% in Q2 2021.
  • Median Return on Sales over the past 5 years was 0.1% (2023), compared with a mean of 0.09%.
  • Biggest five-year swings in Return on Sales: decreased -17bps in 2021 and later rose 12bps in 2025.
  • Haemonetics' Return on Sales stood at 0.06% in 2021, then skyrocketed by 75bps to 0.11% in 2022, then dropped by -14bps to 0.09% in 2023, then rose by 16bps to 0.11% in 2024, then rose by 23bps to 0.13% in 2025.
  • The last three reported values for Return on Sales were 0.13% (Q4 2025), 0.12% (Q3 2025), and 0.11% (Q2 2025) per Business Quant data.